Research news
Development of new Parkinson’s treatments is only possible if everyone is part of the research process. We need your help to push promising research forward.
Latest study results show a new test could help diagnose Parkinson’s before damage occurs to brain cells.
Results from a study of a technique known as focused ultrasound have shown a benefit for people with Parkinson’s with movement problems, for up to a year after treatment.
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson’s.
NICE has conditionally recommended 5 remote monitoring devices for Parkinson’s for use in the NHS in England.
A Lord’s inquiry supported by Parkinson’s UK has recommended the UK government urgently prioritises funding and support for clinical research.
Results from a large study show how changes in certain bacteria may play a part in the development and progression of Parkinson’s.
Through the Parkinson’s Virtual Biotech, we’re investing £1.1m to co-fund a study looking at whether a cough medicine, ambroxol, has the potential to slow the progression of Parkinson’s.
Results from a clinical trial looking at reducing iron levels in the brain have shown no benefit for unmedicated people with Parkinson’s.